TMO vs. AZN, NVS, ABT, ABBV, AMGN, PFE, ISRG, MRK, SNY, and ELV
Should you be buying Thermo Fisher Scientific stock or one of its competitors? The main competitors of Thermo Fisher Scientific include AstraZeneca (AZN), Novartis (NVS), Abbott Laboratories (ABT), AbbVie (ABBV), Amgen (AMGN), Pfizer (PFE), Intuitive Surgical (ISRG), Merck & Co., Inc. (MRK), Sanofi (SNY), and Elevance Health (ELV). These companies are all part of the "medical" sector.
AstraZeneca (NASDAQ:AZN) and Thermo Fisher Scientific (NYSE:TMO) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings, community ranking, media sentiment and profitability.
20.4% of AstraZeneca shares are held by institutional investors. Comparatively, 89.2% of Thermo Fisher Scientific shares are held by institutional investors. 0.3% of Thermo Fisher Scientific shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
In the previous week, AstraZeneca had 7 more articles in the media than Thermo Fisher Scientific. MarketBeat recorded 22 mentions for AstraZeneca and 15 mentions for Thermo Fisher Scientific. AstraZeneca's average media sentiment score of 0.99 beat Thermo Fisher Scientific's score of 0.72 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media.
AstraZeneca pays an annual dividend of $1.93 per share and has a dividend yield of 2.5%. Thermo Fisher Scientific pays an annual dividend of $1.56 per share and has a dividend yield of 0.3%. AstraZeneca pays out 94.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Thermo Fisher Scientific pays out 10.0% of its earnings in the form of a dividend. AstraZeneca has raised its dividend for 1 consecutive years and Thermo Fisher Scientific has raised its dividend for 7 consecutive years.
AstraZeneca has a beta of 0.47, indicating that its share price is 53% less volatile than the S&P 500. Comparatively, Thermo Fisher Scientific has a beta of 0.8, indicating that its share price is 20% less volatile than the S&P 500.
Thermo Fisher Scientific has lower revenue, but higher earnings than AstraZeneca. AstraZeneca is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.
Thermo Fisher Scientific has a net margin of 14.20% compared to Thermo Fisher Scientific's net margin of 13.30%. Thermo Fisher Scientific's return on equity of 30.42% beat AstraZeneca's return on equity.
AstraZeneca presently has a consensus target price of $81.00, indicating a potential upside of 5.33%. Thermo Fisher Scientific has a consensus target price of $607.35, indicating a potential upside of 2.02%. Given Thermo Fisher Scientific's higher probable upside, analysts clearly believe AstraZeneca is more favorable than Thermo Fisher Scientific.
Thermo Fisher Scientific received 999 more outperform votes than AstraZeneca when rated by MarketBeat users. Likewise, 81.12% of users gave Thermo Fisher Scientific an outperform vote while only 58.06% of users gave AstraZeneca an outperform vote.
Summary
Thermo Fisher Scientific beats AstraZeneca on 15 of the 21 factors compared between the two stocks.
Get Thermo Fisher Scientific News Delivered to You Automatically
Sign up to receive the latest news and ratings for TMO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TMO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Thermo Fisher Scientific Competitors List
Related Companies and Tools
